LGSOC is a biologically distinct variant of ovarian cancer, with limited treatment options, that is generally less responsive to conventional chemotherapy

FDA Grants Fast Track Designation for TRE-515 in Combination with KRAS G12C Inhibitors for the Treatment of Non-Small Cell Lung Cancer

2026-10-01T15:33:00Z

LOS ANGELES, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that the U.S. Food...

Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss

2026-10-01T15:30:00Z

In a predefined MRI substudy, trevogrumab prevented 70% of muscle loss associated with semaglutide treatment

Bloom Healthcare Brings Its Proven In-Home Care Model to Dallas-Fort Worth Seniors

2026-10-01T15:00:00Z

Home-based geriatric care model brings personalized primary care to seniors across the region

Michigan Contact Lens Opens 1-800-DRY-EYES Center in Expanded Southfield Facility

2026-10-01T14:45:00Z

One year after relocating from Oak Park and nearly tripling its floor space, the specialty practice has opened a dedicated center for severe dry eye alongside two stations for teaching...

Government of Saskatchewan proclaims October Health Literacy Month

2026-10-01T14:30:00Z

SASKATOON, Saskatchewan, Oct. 01, 2026 (GLOBE NEWSWIRE) -- You trust health information to help you make important decisions. But when medical terms are unfamiliar, information is difficult to find, or...

HealthEdge Launches Unified AI-Powered Platform to Guarantee Financial Outcomes for Health Plans

2026-10-01T14:00:00Z

Unified platform combines technology, implementation and operational expertise to reduce administrative costs, lower transformation risk and drive continuous performance improvement

Amplio Pharma Reports Positive Early Clinical Results for NovoBioJect, Designed to Make the World's Most-Used Rheumatoid Arthritis Drug Work for More Patients

2026-10-01T13:53:13Z

A single dose of NovoBioJect increased the active form of methotrexate inside patients' immune cells by 38%, a first step toward a potential next-generation first-line treatment for rheumatoid arthritis

Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts

2026-10-01T13:30:00Z

Press release – No. 19 / 2026

Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration

2026-10-01T13:28:49Z

MDS-UPDRS motor scores demonstrated stability to baseline recorded at study entry with no disease progression among the 12 evaluable participants who completed 12 months of daily oral administration of rexaceract...

Crohn’s and Colitis Canada Invests $1.5 Million to Advance IBD Research and Future Care

2026-10-01T13:20:00Z

Four Canadian research teams will investigate new approaches to understanding, treating and preventing Crohn’s disease and ulcerative colitis

Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic

2026-10-01T13:20:00Z

CEO Discusses How Addition of Accomplished Oncology Drug Developer Strengthens Ernexa Ahead of Clinical Development Following ERNA-101 Data Demonstrating Complete Tumor Clearance and 100% Survival in Combination with anti-PD-1

BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter

2026-10-01T13:15:00Z

SUNNYVALE, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported...

European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀

2026-10-01T13:15:00Z

PolyPid Submitted Marketing Authorization Application to European Medicines Agency for D-PLEX₁₀₀ Last month

Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities

2026-10-01T13:11:50Z

Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities

Doheny Eye Institute Experts to Share Groundbreaking Insights at the American Academy of Ophthalmology 2026 Annual Meeting

2026-10-01T13:02:00Z

Doheny-UCLA clinicians will participate in more than 30 educational sessions, scientific papers and posters covering retinal disease, glaucoma, pediatric ophthalmology and other areas of eye care

AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data

2026-10-01T13:02:00Z

Recent biotech media features focus on Ampligen’s potential to address immune resistance in metastatic pancreatic cancer and the clinical progress of the Phase 2 DURIPANC program